External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance
Nucleic acid testing (NAT) for malaria parasites is an increasingly recommended diagnostic endpoint in clinical trials of vaccine and drug candidates and is also important in surveillance of malaria control and elimination efforts. A variety of reported NAT assays have been described, yet no formal...
Main Authors: | Murphy, S, Hermsen, C, Douglas, A, Edwards, N, Petersen, I, Fahle, G, Adams, M, Berry, A, Billman, Z, Gilbert, S, Laurens, M, Leroy, O, Lyke, K, Plowe, C, Seilie, A, Strauss, K, Teelen, K, Hill, A, Sauerwein, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2014
|
Similar Items
-
External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance.
by: Sean C Murphy, et al.
Published: (2014-01-01) -
Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
by: Paul M. Luethy, et al.
Published: (2018-01-01) -
Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium
by: Kirsten E. Lyke, et al.
Published: (2018-02-01) -
A research agenda to underpin malaria eradication.
by: Alonso, P, et al.
Published: (2011) -
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines.
by: Laurens, M, et al.
Published: (2012)